 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today provided a company update and announced second quarter 2020 financial results. Net revenues from continuing operations during the quarter were 9.6 million. Combined revenues from continued and discontinued operations were 10.3 million, as the company recorded an additional 750,000 in revenue in the second quarter associated with divested product rights. 